AlphaMet Overview
AlphaMet, formerly CyclaPlex, develops, manufactures, and markets the "CyclaPlex Correction System", an implant device designed to prevent bone osteotomy, shorten recovery time, reduce pain, and help patients get back to normal within days of undergoing bunion surgery. CyclaPlex is FDA cleared for use by surgeons and is distributed in the U.S. by Genesis Ortho Partners.
Cumulative Funding Raised Over Time ($)
Latest News
Israeli company will treat bunions worldwide
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $820K |
| Last funding | $140K |
| Stage | Mature |
| Rounds | 3 |
| Investors | 1 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | alphametone.com/ |
Locations
Bat Shlomo, Israel
600 15th St, Miami Beach, FL 33139, USA
Photos & Videos
1 item(s)
